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CHAPTER 1
Introduction: Dimensions of the Problem
Background Information and Statement of the Problem
Each year approximately 240 out of 100.000 persons are diagnosed with knee
osteoarthritis (Hatik. 2014). Increasing population with knee osteoarthritis also
increases the economic burden on the U.S. A total of $43,582,648 is spent in noninpatient management options of knee osteoarthritis prior to total knee replacement
(Bedard et ah, 201 8). An aging population, increasing obesity rates, and intensified
focus on a more active elder population may all contribute to the prevalence of knee
osteoarthritis, thus the overall emotional and physical health of the U.S. population
(Centers lor Disease Control and Prevention [CDC], 2018b). The American Academy
of Orthopaedic Surgeons (AAOS) set forth evidence-based practice guidelines in the
hopes of improving the overall management options of osteoarthritis.

Purpose of the Research Project
The purpose of this study was to determine the compliance of primary care
providers with AAOS guidelines of knee osteoarthritis (OA) and identify the most
commonly used management options chosen by primary care providers for knee
osteoarthritis. In the future, patients' healthcare costs for osteoarthritis will increase;
therefore, it is important to evaluate how compliant primary care providers are with
evidence-based guidelines compared to their preferred treatment for OA. Hopefully,
this study will help to identify future educational needs of primary care providers in
order to ensure these evidence-based practice guidelines are followed and patient
outcomes associated with these guidelines may be met.
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Significance of the Research Project
Over hall ol adults in the U.S. diagnosed with knee OA will undergo a total
knee replacement (CDC, 2018a). From 2013-2015, an estimated 54.4 million U.S.
adults annually have never been told by a doctor that they had some form of arthritis,
rheumatoid arthritis, gout, lupus, or fibromyalgia. By 2040, an estimated 78 million
U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis
(CDC, 2018b). lire risk of arthritis increases with age. OA is the most common form
of arthritis and a significant cause of pain and disability in older adults (Loeser, 2018).
Among the risk factors for OA, age is the most prominent (CDC, 2018b). It is
estimated that 4.0 million adults in the U.S. currently live with a total knee replacement
and represent 4.2% of the population 50 years of age or older. Research has found that
a total of $43,582,648 is paid for outpatient management of OA of the knee before total
knee replacement is performed (Bedard et ah, 2018). Research found that the total cost
per year per person who is newly diagnosed with OA patient is $6,811 and $6,407 for
existing patients (Le, Montejano, Zhun, Yang, & Dennis, 2012). Compliance rate with
the AAOS guidelines is low, and evidence of continual use of non-recommended
treatment/management options has been noted (Carlson et al., 2018).

Conceptual Framework
The Chronic Care Model (CCM) is a multi-component, evidence-based
framework guide used by providers to implement during patient care to help provide a
higher quality of care while reducing overall cost of treatment for chronically ill
patients. This care model is composed of six components: delivery system design, selfmanagement support, decision support, clinical information support, community

•~)
J

resources and policies, and health care organization (Boville et ah. 2007). The CCM
was designed to educate patients on their level, so they will have a better understanding
oi their disease process. The design of this model was to educate patients on the effects
it has on their health, educate how to self-manage with medications, skills, and daily
lifestyle habits that affect their disease process. The interdisciplinary team consists of
physicians, nurses, case managers, dieticians, and educators. Community resources are
provided to the patient for dietary programs, health clubs, and home care agencies.
Dr. Edward Wagner helped discover and implement the CCM in the early
1990s. Dr. Wagner was an internist and director of the Seattle-based MacColl Institute
for Healthcare Innovation at the Center for Health Studies, Group Health Cooperative
(Isaac & Knickman, 2006). Several areas were identified in order to provide better
patient care. Some of those findings

included educating the patient, having the patient

be involved in their own care, and be compliant for a better long-term effect on their
chronic illness. Dr. Wagner also determined whether or not patients had self-care
support outside of the doctor's office. Another issue identified was that providers were
too busy to educate and support patients with chronic illnesses in a manner to keep them
healthy.
This theory focused on a few specific chronic illnesses, such as asthma,
diabetes, or depression. Dr. Wagner also wanted the providers and interdisciplinary
team to have computerized charting, so the patients could easily be identified and notify
the team of the patients' needs. In 1994. the Robert Wood Johnson Foundation offered
Dr. Wagner a grant to refine the CCM to a foundation-supportive initiative called
Improving Chronic Illness Care Program. This program was designed to give a broader
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range of attention to chronic illness and serve as a guide, so providers can meet the
needs of chronically ill patients more efficiently (Isaac & Knickman, 2006). "This
model places the patient at the center of the care process" (Boville et ah. 2007, p. 360).
Those patients who are compliant with care help improve or stabilize their health. The
providers and patients also have a better relationship, understanding, and trust when it
comes to the care of an individual.
The CCM relates to the current research project because it focuses on the
interventions that are being provided by the providers. It also helps to identify the
compliance of primary care providers with AAOS guidelines of knee osteoarthritis.
Osteoarthritis is a chronic illness that can have lifelong debilitating effects on an
individual's health and can cause a financial burden. Early prevention is the key. For
example, if an obese patient has access to a dietary coach or physical fitness support, he
or she can encourage the patient to lose weight. By them losing weight it will be less
strenuous on their joints. Another example includes a noncompliant patient regarding
follow-up appointments and never having transportation to the clinic. The office can be
proactive and schedule transportation for the patient, so they can attend all clinic
appointments. When providers follow the recommended guidelines, educate the
patient, and are supportive of the patient, it can decrease the overall cost of treatment.
The patients will also feel like they are receiving good quality care.

Research Questions
Increase in the number of cases of osteoarthritis in U.S. will be seen in the near
future among adults and the geriatric population (CDC, 2018a). The AAOS Treatment
of Osteoarthritis of the Knee Evidence-based Guidelines (2nd edition) was published in
2013. Previous researchers had found that recommended treatment/management
options for knee osteoarthritis were not being utilized among those providers treating
this disease (Bedard et ah. 2017; Dhawan et ah, 2014). Researchers also found that
many providers are still unaware that evidence-based guidelines are available for the
treatment of osteoarthritis; therefore, this study will explore the following claims.
The current research was based on the following research questions:
1. Are primary care providers compliant with the AAOS treatment of osteoarthritis of
the knee guidelines?
2. What are the most common treatment/management options chosen by primary care
providers for knee osteoarthritis?
Definition of Terms
For the purpose of this study, the following terms were defined:

Primary care provider
Theoretical: "The healthcare provider, nurse practitioner, physician's assistant,
or physician to whom a patient goes to address a problem with his or her health"
(Yenes. 2017. p. 1933).
Operational: A primary care provider who will be providing medical care,
education, and prevention to individuals with joint pain.
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Operational: The use of AAOS guidelines in the treatment of patients with knee
osteoarthritis by primary care providers.
American Academy of Orthopaedic Surgeons (AAOS)
Theoretical: Provides education and practice management services for
orthopaedic surgeons and allied health professionals. AAOS (2018) also serves as an
advocate for improved patient care and informs the public about the science of
orthopaedics.
Operational: An organization that provides recommended evidence-based
guidelines for optimal orthopaedic patient care.
Guidelines
Theoretical: "An instructional guide or reference to indicate a cause of action in
a specific situation" (Venes, 2017. p. 1051).
Operational: Guidelines provided from AAOS as an evidence-based reference
for providers to stay current with the most up-to-date information to provide optimal
care for patients with joint pain.
Osteoarthritis of knee
Theoretical. "Arthritis marked by progressive deterioration of cartilage in
synovial joints and vertebrae. The dominant side of the body is involved more often
than the non-dominant side. Affected joints become enlarged, lose range of motion,
make sounds, or feel noisy or creaky" (Venes, 2017, p. 1708).
Operational: Patients who have degenerative joint disease involving the knee.
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I reatment/management options

Theoretical: "Medical, surgical, dental, or psychiatric management

of a patient."

(Venes, 2017, p. 2400).

Operational: Methods of application or employment of any therapeutic agent,
device, or treatment used by primary care providers to treat knee osteoarthritis.

Assumptions
1 he current researchers made three assumptions in regard to certain aspects of
the study. These assumptions are listed below:
1.

for the purpose of this study, the researchers assumed that all participants
responded to the survey with honest answers for the study.

2.

Primary care providers are aware of the AAOS guidelines and use evidence-based
practice to treat patients with knee OA.

3. Primary care providers are familiar with the treatment/management option choices.

Limitations of the Research Project
The limitations identified for this study were as follows:
1.

The current study was not able to assess the influence of patient requests
regarding the treatment/management options selected by the primary care providers
on the survey.

2.

The primary care providers were only able to choose the three most common
treatment/management options.

3.

The study cannot be generalized
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CHAPTER II
Review of Literature
The following literature review provided a context for the current study.
Articles concerning compliance, treatment/management options and the chronic care
theoretical model were reviewed in order to support the current research.
Conceptual Framework
Several studies have shown that compliance with the Chronic Care Model
(CCM) has an overall effect on the patients and is more cost effective. For example, in
a recent study with patients who had a stroke or transient ischemic attack, a team of care
members were assigned to follow up with the patients in their home, provide a more indepth education for them and their family members, teleconferences, phone interviews,
and equipment offered for self-monitoring, e.g., blood pressure and glucose. By the
patient having all these resources, it helped them be more conscious of being compliant
regarding their illness. "The overwhelming majority of strokes each year could be
prevented through awareness and optimal management of hypertension, and through
lifestyle changes to healthier diets, greater physical activity, and smoking cessation"
(Towfighi et ah, 2017. p. 2).
Another study showed a decrease in LDL lab results when the providers and
interdisciplinary team used the CCM approach to better assist the patient with his or her
chronic condition. For instance, a program called Key Driver Implementation Scales
(KDIS) documents monthly the progress and implementation the provider provided to
the patient. The score ranged from 0 to 5 with 0 being no implementation towards the
patient's chronic illness.
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In accordance with this, the point estimate trends suggest that improved LDL
control is associated with increasingly higher degrees of implementation of these
activities in a dose-response relationship. Our model also suggests that practices
without any activity or improvement in KD1S score saw worsening of their LDL
performance. (Halladay et ah, 2014, p. 38)
1 he CCM related to the current research project because it focused on the
interventions that are being provided by the providers and to identify the compliance of
primary care providers with AAOS Treatment of Osteoarthritis of the Knee Evidencebased Guidelines. Osteoarthritis is a chronic illness that can have lifelong debilitating
effects on an individual's health and can also cause a financial burden. Early prevention
is the key— not to mention when providers educate the patient, provide support to the
patient, and follow recommended guidelines, it will decrease the overall cost of
treatment in the long run (Towfighi et ah. 2017). The patients will also feel like they
are receiving the best care by their provider.

Review of Related Research
Dhawan et al. (2014) conducted an epidemiologic analysis to determine if the
treatment of OA of the knee was based on the current guidelines set forth by the AAOS
and also to determine the non-arthroplasty treatment patterns. In relation to the older
population in the U.S., osteoarthritis is the leading cause of disability and is one of the
leading contributors to healthcare costs. Millions of people are diagnosed with
osteoarthritis each year in the U.S. alone. Although osteoarthritis has no known cure to
date, there are several treatment/management options that have been introduced to
diminish its effects. Clinical practice guidelines (CPGs) have been developed by
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numerous organizations to optimize the treatment of osteoarthritis. However, 110
theoretical framework was identified for this study.
Dhawan et al. (2014) hypothesized that practice patterns would closely align
with the recommendations set forth by AAOS CPGs. Dhawan et al. sought to prove
this hypothesis by analyzing current practice patterns and assessing the impact made by
AAOS guidelines.
The database used as a resource for this study was the United Healthcare
database (UHD). This database includes inpatient as well as outpatient participants. It
also includes physician charges from orthopaedic records. In order to target a specific
population. Dhawan et al. (2014) collaborated with Pearl Diver Technologies. This
allowed the study to pinpoint orthopaedic patients based on International Classification
of Diseases, Ninth Edition, Clinical Modification (ICD9) codes. Current Procedural
Terminology, Fourth Revision (CPT-4) codes were also used. The technology allowed
the database to be searched with Boolean search language. The index group consisted
of patients with end-stage osteoarthritis and was defined by those who were treated with
any knee arthroplasty and also had a diagnosis of osteoarthritis. No timeframe was
mentioned for this study.
The study found that in the index group, 1,286 (10%) and 146,891 (25.9%) from
the broader group received physical therapy. In relation to mechanical interventions,
which includes heel wedges and varus/valgus-directing knee braces, 5,187 (1.0%) of
patients in the broader group received one of these interventions. No patients in the
index group were prescribed a heel wedge, and only 329 (2.6%) were prescribed a
brace. Complementary and alternative therapy included acupuncture therapy treatment.

In the index group, only 66 (0.52%) received this treatment, and only 2,103 (0.4%) of
patients from the broader group were coded for acupuncture treatments. A total of
5,580 patients (43.5%) from the index group and 93,348 (16.6%) from the broader
group received intra-articular injections. In regard to non-arthroplasty surgical options,
AAOS does not recommend arthroscopic interventions in those who do not have a
diagnosis ot a meniscal tear or loose body. It was found that, in spite of the AAOS
recommendation, 877 patients (6.8%) within the index group still underwent
arthroscopy. In the broader group, 64,867 patients (11.5%) underwent arthroscopy; of
those, 21,349 (32.9%) did not have a diagnosis of meniscal tear or loose body. Through
this study, the researchers determined that AAOS guidelines were not being
implemented properly. They also determined that several CPGs were being underused.
The study determined that, in spite of AAOS CPG recommendations, arthroscopy is a
management option that is frequently used. The current researchers recommend that for
future studies a controlled experiment should be included on implementation and
adherence to recommended guidelines.
Dhawan et al. (2014) recognized certain limitations to their research. First, they
recognized that the study did not include an analysis of the factors that influence
adherence to guidelines. These factors include specialties, such as sports medicine,
adult reconstruction and primary care, and patient characteristics, such as age, gender
and body mass index. Secondly, they recognized that the databases did not allow
evaluation of every guideline. Thirdly, they recognized that they were unable to
evaluate the practice patterns in relation to when the guidelines were released.
Fourthly, they acknowledged that the accuracy of findings was limited by how
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accurately the physicians code each diagnosis and treatment. Lastly, the mining
piotocol itself was limited due to various variations in coding.
In conclusion. Dhawan et al. (2014) provided for an excellent comparison tool
foi the current research concerning current guideline adherence among primary care
providers. The current study sought to identify if primary care providers are following
recommended guidelines concerning knee osteoarthritis, and it also sought to determine
the treatment/management options most commonly chosen. The research by Dhawan et
al. inferred that evidence-based guidelines are not often adhered to. Dhawan et al. also
found that arthroscopic interventions were utilized in numerous cases that, according to
AAOS guidelines, are not recommended. The current researchers used this study as a
comparison tool for their research and hopefully helped determine if guidelines are
being followed more closely or if there has been no change. The results of this study
revealed that provider education concerning management of osteoarthritis of the knee
should be provided. Numerous treatment/management options are recommended that
can help alleviate the symptoms of osteoarthritis and provide patient relief.
Carlson, Ong, Orozco, Hernandez, Lutz, and Post (2018) performed a study for
the purpose of determining compliance of members of the American Association of Hip
and Knee Surgeons (AAHKS) with AAOS guidelines for treatment of knee OA. In
2008. the AAOS published guidelines for the nonsurgical treatment of knee OA. These
guidelines were updated in 2013. In 2015, the AAOS published guidelines for the
surgical treatment of knee OA. These guidelines were based on evidence-based
research, and the AAOS developed these guidelines in order to improve overall patient

outcomes for those who suffered with knee OA. No theoretical framework was
identified for this study.
Carlson et al. (201 8) conducted this study to answer the question of how
effectively AAOS guidelines are used by orthopaedic surgeons and to what extent this
tieatment resulted in positive outcomes. Carlson et al. hypothesized that orthopaedic
surgeons comply with the AAOS guidelines and use this resource to modify their
practice and treatment/management options for knee OA.
The Carlson et al. (2018) study was conducted by completing survey
questionnaires via Google forms survey platform. The population consisted of the
members of the AAHKS. All participants were contacted by email in June 2016 and
were asked to complete the survey online. Participants were classified by their
subspecialties which were operative and joints (94.8%), operative and sports (2%),
operative and other (2%) and nonsurgical (1.2%). The questionnaire was used to elicit
current treatment preferences. AAHKS health policy and research committee members
also collaborated with the author to design the questionnaire and assisted in distributing
the surveys that contained five vignettes. Carlson et al. (2018) also utilized human
participant regulations during distribution and management of data to guarantee
confidentiality of samples. These data were used to identify the number of times the
recommended treatment was used for each pathologic stage of osteoarthritis and for all
clinical vignettes combined. Carlson et al. used Fleiss "k" coefficient to assess
agreement for all vignettes combined. The key variables to the study were the
knowledge and experience of the physicians as it could have had an impact on the
selection of treatment/management options, thus affecting the Fleiss coefficient.
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Statistical analysis ot collected data showed that Carlson et aids' (2018)
hypothesis was untrue. Out ol 345 samples of orthopaedic surgeons who completed the
survey, the use of AAOS recommended interventions was 80% for OA stage 0. 82% for
OA stage 1,21% for stage 2, 50% for stage 3, and 98% for stage 4. Carlson et al. also
noted that many orthopaedic surgeons are using intra-articular (IA) hyaluronic acid for
osteoarthritis stages 2 and 3. I his intervention is not recommended by AAOS
guidelines with strong supporting evidence. Carlson et al. (2018) concluded that
orthopaedic surgeons are not following the current AAOS guidelines for the treatment
ol moderate to severe osteoarthritis and noted the excessive use of 1A injections.
Carlson et al. (2018) also recommended performing further studies to clarify the role of
intra-articular injections of corticosteroids in treatment of knee osteoarthritis and studies
to educate orthopaedic surgeons about AAOS guidelines.
Carlson et al. (2018) identified two limitations to their study. First, there was a
restriction on the number of management options that could be selected for each
vignette. Carlson et al. assumed that if multiple options could be selected there would
have been an increase in the percent of compliance with the AAOS guidelines. Second,
they were not able to assess the influence of a patient's request on the selection of a
management options by the physician.
The final conclusions of this study by Carlson et al. (2018) were that
orthopaedic surgeons were not complying with the AAOS guidelines for OA treatment.
This provided a strong foundation for the current research. Permission was given and
the survey using the same five vignettes were modified for the current students'
research.
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Bedard et al. (2017) conducted a study in which they sought to determine knee
OA costs m the year leading up to a total knee arthroplasty (TKA). One of the leading
causes of disability in the U.S. is osteoarthritis, and increasing numbers of the
population aie becoming affected. Although TKA has proven to be an effective
tieatment loi osteoarthritis of the knee, there are clinical practice guidelines (CPGs) that
should be followed before a J KA is performed. These guidelines were put forth by the
AAOS Clinical Practice Guidelines for the Treatment of Osteoarthritis of the Knee (2nd
edition) (2013) and should be utilized in the non-operative management of knee OA.
Despite guidance of the CPG and the previous CPG, many non-recommended
treatments are still utilized. No theoretical framework was identified for this study.
Bedard et al. (2017) stated that their hypothesis for this study was that in the
year prior to a TKA the majority of costs were associated with knee OA interventions
that were not supported by AAOS CPG. Bedard et al. sought to prove this hypothesis
through a series of research that would give insight into the treatment/management
options utilized in the year leading up to a TKA. Bedard et al. would then determine if
these interventions were recommended by the AAOS CPG. By answering these
questions, they could then compare costs for each patient undergoing TKA and
determine if the costs were necessary or unnecessary. Bedard et al. (2017) made
reference to the importance of this research due to the emphasis now placed on valuebased healthcare.
Bedard et al. (2017) conducted their research through the Humana, Inc.
administrative claims database. The initial dataset included all patients undergoing
primary' TKA from 2007 to the second quarter of 2015. This dataset was composed of
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20 million patients initially and were identified by using the Current Procedural
Terminology (CPT) code 27447 and International Classification of Diseases (9th
Revision (ICD-9) code 81.54 for primary TKA. Utilizing the Pearl Diver Research
Program, Bedard et al. (2017) were able to track billing records for each patient for the
year prior to the TKA. I hey began filtering billing codes to only include ICD-9
diagnosis of knee OA and then further filtered the results by including only noninpatient reimbursements specifically associated with knee OA. Treatment
interventions assessed through CPT codes included hyaluronic acid (HA) injection,
corticosteroid injection (CS), physical therapy (PT), braces, wedges, insoles, opioids,
prescription non-steroidal anti-inflammatories (NSAIDS), and tramadol. These
treatments were only assessed when they were directly linked to a diagnosis of knee
OA. Costs were stratified based on AAOS CPG. The CPG strongly recommended
were PT. NSAIDS. and tramadol. The management options not recommended were
wedge insoles and HA injections. With these filters, the dataset was comprised of
86,081 patients.
Results of this study revealed that the average cost per patient for non-inpatient
management of knee OA was $506, which equaled $43,582,648 for the year prior to
TKA. The three most commonly used treatments were discovered to be HA injections,
CS injections, and opioids. These three interventions had no recommendation
supporting their use but yet represented 43% of non-inpatient costs associated with knee
OA and were found to be used in 56,690 (65.9%) patients. HA injections alone made
up 29.2% of non-inpatient costs for knee OA. Out of the eight therapeutic
interventions, only three were recommended by the AAOS CPG. The study found that
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in spite of this, 29.3 ^ ol the costs were associated with the interventions not
recommended (Bedard et ah, 201 7)
Bedard et al. (201 7) acknowledged numerous limitations to their research. First,
the> identified that their study was dependent on the accurate documentation and coding
in the administrative claims database. Bedard et al. also acknowledged that the
numbers were likely underrepresented for the true prevalence of these
treatment/management options as well as the likelihood of these treatments being
prescribed to patients with knee OA who were being treated under other knee pathology
ICD-9 codes, such as meniscal tear, loose body, and chondromalacia and so on. The
costs for these interventions can also vary based on geographic location and insurance
providers. The true costs may also be underestimated based on the fact that some
treatments, such as NSAIDs or knee braces, can be purchased over-the-counter and
without the involvement of insurance carriers. The last limitation Bedard et al.
acknowledged was that, although there were no data regarding efficacy of the
interventions, it was likely that they were mostly unsuccessful in alleviating symptoms
since most patients underwent TKA within a year or less.
Although Bedard et al. (2017) investigated the costs associated with knee OA
prior to a TKA, it is very relevant to the current students' research based on the findings
concerning treatment/management options being utilized. Bedard et al. (2017) provided
documentation that AAOS CPGs are not being adhered to and that
treatment/management options not recommended are being frequently used. The results
of this study were alarming and raised concerns that PCPs are not educated well enough
on the current CPG. The current students' research sought to identify this while also
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raising awaieness among PCP ol the AAOS CPG. This is vitally necessary in order for
the patients suffeiing from OA to receive the highest quality of care possible.
Atukorala et al. (2016) performed a study to examine dose-response relationship
between weight loss and its effect on improvement of symptoms of knee osteoarthritis.
Atukorala et al. mentioned in the study that symptomatic knee osteoarthritis is the cause
of lower extremity disability and poor life quality. Atukorala et al. also mentioned that
there was an increase in the incidence of obesity seen among older age groups. Since
obesity is an important risk factor for knee osteoarthritis, this increases the chances of
seeing increased numbers of knee osteoarthritis cases in the future. Atukorala et al.
mentioned that a previous meta-analysis by Christensen. Bartels, Astrup. and Bliddal
(cited in Atukorala et al., 2016) concluded that moderate to large improvements in selfreported disability were seen with > 5% weight loss. In addition, a study conducted by
Brand et al. (cited in Atukorala et al., 2016) concluded that clinicians do not encourage
weight loss to their patients. The significance of the Atukorala et al. (2016) study was
that this was the first study that was community-based and would determine how weight
loss can improve the ability of performing activities of daily living and also improve
symptoms of knee osteoarthritis. No theoretical framework was identified for this
study.
Atukorala et al. (2016) hypothesized that the effects of the interventions, such as
strength, balance, mobility, exercise, personal support and pain management strategies,
were steady across the cohort and would not impact the result of the study. The study
mainly relied on the self-reported weight assessment and hypothesized that they were
error free (Atukorala et al., 2016).
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The method of the study utilized participants in the Osteoarthritis Healthy
Weight tor Life Program (OAHWEL), which is an 18-week community-based program
for weight loss of 7% to 10% by diet changes. The participants were evaluated with a
Knee Injur}-' and Osteoarthritis Outcome Score (KOOS) survey that contained 42
questions. 1 he questionnaires broadly evaluated five categories, such as pain, various
symptoms, functions in daily living, function in sports and recreation, and knee-related
quality of life. Each section was scored separately by using a 5-point Likert scale in
which 0 was no problems and 4 was extreme problems. All participants in the study
had a current or history of knee osteoarthritis supported by radiology and any previous
arthroscopy and a body mass index > 28. The participants also needed to have knee
osteoarthritis symptoms that required a referral to an orthopaedic surgeon for evaluation
of knee replacement surgery. The OAHWEL participation criteria were persons age 50
years or older with knee osteoarthritis who were willing to participate in the OAHWEL
program and had approval from their general practitioner, orthopaedic surgeon, or
rheumatologist who confirmed participants' diagnosis of knee osteoarthritis. The
sampling method for the study included participants who completed the OAHWEL
program. They were then asked to fill out the KOOS questionnaire. The uncovered
variable evaluated was the extent of body weight list (%) from benchmark to the weight
surveyed at 18 weeks of follow-up. "t he Western Ontario McMaster Universities
Osteoarthritis Index (WOMAC) function score was taken from KOOS. A higher-level
of pain, stiffness, and limitations in performing daily living activity would give a higher
score on the WOMAC index.
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Atukorala et al. (2016) interpreted the data as a clear relationship between
weight loss and symptom improvement in overweight and/or obese groups who
underwent a standardized weight loss program in a community-based setting. Weight
loss was related to a major improvement in pain levels and functions. The study found
that 7.7% or greater weight loss is needed to gain a "minimal clinically important
improvement (MCII) in functions. Atukorala et al. identified from different research
that weight loss is associated with a decrease in knee joint loading and peak knee
compression forces that reduce pain and reduce inflammatory markers like TGFfk IL-1 (3
and tumor necrosis factor a, hence reducing pain and knee osteoarthritis symptoms.
Atukorala et al (2016) concluded that weight loss in participants who had better
baseline functions also showed a clinically important improvement in functions.
Therefore, it shows the usefulness of weight management in all patients with knee
osteoarthritis regardless of their functional status. Further recommendations for future
studies given by Atukorala et al. were to assess the escalating risk factor of obesity in
persons with knee osteoarthritis, replicating this study with a controlled group and
weight loss group to find the extent of influence of an exercise program to weight loss,
and evaluating the cost-effectiveness of weight loss programs in knee osteoarthritis.
Atukorala et al. (2016) identified many limitations to the study. First, the study
did not have a control group: this was not possible for this study as they were using a
retrospective assessment of data collected by OAHWET. Secondly, the OAHWEL
program used strength, balance, mobility, exercise, personal support, and pain
management strategies as intervention along with the dietary components. However,
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Atukorala et al. (2016) did not discuss the effect of these interventions on the result.
Lastly, data of the study were self-reported weight assessments (Atukorala et ah, 2016)
1 he current students' research sought to determine the compliance of Primary
Care Provider with AAOS Clinical Practice Guidelines for the Treatment of
Osteoarthritis of the Knee (2013). This study provided a strong base showing how the
AAOS recommended intervention of weight loss will promote improvement in
functional ability and a reduced pain level in persons with knee osteoarthritis.
Barnes, Theeke. and Mallow (201 5) performed a longitudinal controlled study
for the purpose of evaluating the Provider and Healthcare Team Adherence of
Treatment Guidelines (PHAT-G) for obesity in primary care while complying with the
clinical practice guidelines. Three phases in the project were used to help determine the
outcome of adherence: Phase 1. the baseline assessment of provider adherence; Phase 2,
the implementation of the interventions for PHAT-G; and Phase 3, the evaluation of
adherence to the diagnosing and treatment of overweight and obesity according to the
recommended clinical guidelines. This project aimed to achieve the following three
goals:
1. Have the providers document more body mass index (BM1) calculations in
the chart.
2. More providers will give a diagnosis of obesity in the patient's chart if they
have a BMI > 30.
3. Increase the documentation of a planned weight loss regiment according to
guidelines for overweight or obese patients.
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Obesity is a primary cause of multiple health-related issues that people are
diagnosed with annually, but it is otten overlooked in primary care clinics since the
healthcare system gives priority to other chronic conditions caused by obesity. The
primary care providers use this chronic condition as a diagnosis to receive
reimbursement tor interventions implemented "In June 2013, the American Medical
Association declared obesity to be a disease state with its own unique physiological
factors" (Barnes et ah, 2015, p. 2). Barnes et al. identified the hypothesis that if obesity
is recognized as a disease, then the healthcare system will reimburse the providers for
the interventions they are providing to the patient. This approach in turn will help
reduce the number of obese adults diagnosed yearly.
The study by Barnes et al. (2015) was conducted by evaluating patient health
records to assess baseline and post-implementation data. PHAT-G was implemented by
the School of Medicine in West Virginia. Twelve months prior to starting the project
only 1 % of the patients had a diagnosis of obesity as one of their top three diagnoses
documented in the chart. If the diagnosis was not listed in the first three, then it was not
counted in the study. "However, the fact that so few encounters included obesity as a
top-three diagnosis indicates the lack of priority for this health issue" (Barnes et al.,
2015, p. 4). A sample of 100 medical records determined by Joint Commission
requirements of adult patients ranging from age 18 to 64 years was evaluated in phase
one assessment data and phase three evaluation data.
During phase two is where interventions of education were provided to the
providers and support staff. This phase was implemented to help educate everyone on
proper techniques, such as obtaining correct measurement of height, weight, calculation,
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and documentation ot BMI in the patient's health record. Another important element of
phase two included the reminder system. This system included posters placed
throughout the clinic in plain view of staff and patients to help remind them about
required documentation on BMI. Providers were also given a packet of patient
education and the clinical care guidelines as a tool to help implement during patient
care. Every week, a card was placed in the mailbox of clinical staff by the project
director regarding objectives of the project. Mid-point of the 6-week implementation
phase was audited and communicated via email to clinic staff.
Barnes et al. (2015) identified several limitations within the study that included
only one clinical site where the study was performed. Secondly, the population of the
study was primarily Caucasians. The third limitation was the lack of a control group. It
is possible that interventions outside the factor could have influenced the study. Lastly,
the sample size was chosen by Joint Commission's requirements of a minimum of 70
cases; but, when the sample size of 100 was chosen, this could have allowed an increase
in the analysis of data.
This study by Barnes et al. (2015) had a strong foundation to help build the
current research knowledge. It provided strong evidence that obesity is underdiagnosed
and undertreated. AAOS CPG strongly recommended weight loss as a management
option for knee OA. After completion of the study by Barnes et al. (2015), researchers
did reveal the importance of the interdisciplinary team in the care of overweight and
obese patients and that primary care providers will need to utilize other members of the
team in order to achieve compliance with guidelines.
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Bedaid et al. (201 8) performed a study for the purpose of determining the
influence ot AAOS clinical practice guidelines on the rate of intra-articular hyaluronic
acid and corticosteroid injections in general. Bedard et al. also estimated the usage of
intra-articular hyaluronic acid and corticosteroid injections in patients with the
diagnosis of osteoarthritis of knee in the U.S. by specialty providers. The study was
based on the AAOS Clinical Practice Guidelines for the Treatment of Osteoarthritis of
the Knee published in 2008 and the second edition published in 2013. Bedard et al.
(2018) stated that there was a drastic change in recommendations for use of intra
articular hyaluronic acid and corticosteroid injections from 2008 guidelines to 2013
AAOS clinical practice guidelines (2nd edition). In the second edition, based on strong
evidence, it is recommended not to use hyaluronic acid and failed to provide evidence
to support or oppose the use of intra-articular corticosteroid. Bedard et al. (2018) also
used data for comparison from a similar study in 1996-2013 by Koenig et al. (2015)
(cited in Bedard et al., 201 8) that examined the use of injections in Medicare patients.
No theoretical framework was identified.
Bedard et al. (2018) conducted the study to get answers to the following
questions: Did publication of the 2008 1st edition clinical practice guidelines and the
2013 2nd edition of clinical practice guidelines affect the usage of intra-articular
hyaluronic acid and corticosteroid injections and to see if the utilization rate was altered
with different specialty providers? The authors hypothesized that all patients with an
International Classification of Diseases, 9th Revision (ICD-9) Coding for knee
osteoarthritis were documented correctly, and all specialty providers were aware of the
2008 and 2013 clinical practice guidelines for treatment of knee osteoarthritis.
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The outcome of the study was characterized into four different aspects: overall,
corticosteroid injections, hyaluronic acid injections, and provider specialty. The overall
outcome was out of 1,065,175 patients, 38.0% and 12.9%, respectively, had at least one
injection of corticosteroid and hyaluronic acid. In intra-articular corticosteroid
injections, an increase in rate by 0.29 injections per quarter was noted prior to the
publishing ot 1st edition. However, it did continue to increase but at a sluggish rate
after the publication, and the increase rate continued to decline post publication of 2nd
edition. Interpretation of the findings was no notable change happened in the usage of
intra-articular corticosteroid injections after implementation of both editions of clinical
practice guidelines. As mentioned above, Bedard et al. (2018) also linked injection
usage between young and older patients. This study showed a major increase in
corticosteroid injection usage with no effect of guidelines publications among both age
groups. Hyaluronic acid injections showed an increase of 0.03 injections per quarter
during the total study time. Bedard et al. (2018) noted a sudden decline in rates after
the 1st edition was published; whereas, after the publication of the 2nd edition, change
was noted although it was not abrupt. A decline in total usage of hyaluronic acid
injections was noted at a rate of -0.12 injections per quarter. Hyaluronic acid injections
usage in the entire period did not show any change in younger patients, but in older
patients an increase was noted. No significant change was noted in hyaluronic
injections use after publication of the 1 st edition in younger patients, but a drastic
increase was noted among older patients. Whereas after 2nd edition publication, the
rate declined considerably for younger patients; and, in older patients, the usages began
to notably decrease. The outcome of provider specialty with the administration of
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hyaluronic acid injections was 67% by orthopaedic surgeons, 12% by primary care
physicians, 10% by musculoskeletal specialists, and 2% by pain specialists. On the
other hand, administration of corticosteroid injections was 69% by orthopaedic
surgeons, 14% by primary care physicians, 8% by musculoskeletal specialists, and 2%
by pain specialists. In the total period of the study, the rate of both injection
administrations performed by orthopaedic surgeons and pain specialists increased.
Among primary care providers corticosteroid injection usage was decreased, but no
change was noted tor hyaluronic acid injections. In musculoskeletal specialist group,
no changes were noted in either injection. After the 2nd edition of guidelines was
published, no change was noted in the use of corticosteroid injections, the increase rate
of hyaluronic acid injections declined in pace in orthopaedic surgeons and pain
specialists, and no noteworthy change was noted for other specialty groups. Bedard et
al. (2018) further investigated the effect of different formulas of hyaluronic acid (higher
molecular-weight and cross-linked formulations) as this could cause contradictory
conclusions. Bedard et al. (2018) concluded from the study that published clinical
practice guidelines are not helping and requested implementation of some other
interventions that will inspire change in practice and encourage providing quality of
care to patients with knee osteoarthritis.
The limitations of the study were that the whole research depended on data
collected from administrative claims which solely relied on correct and complete
documentation. Secondly, it was difficult for Bedard et al. to determine the
effectiveness of the corticosteroid and hyaluronic acid injections from the claim data.
Lastly. Bedard et al. only focused on the corticosteroid and hyaluronic acid injections
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used among the patients with the diagnosis of knee osteoarthritis (ICD-9 coding).
Inct eased numbers in usage could have been obtained if other knee pathology codes had
been considered. Strengths of the study were that the analyses of data were accurate to
address each research question. Bedard et al. (2018) also assessed the validity of
administratively coded co-morbidity and compliance data to test their hypothesis that all
data were correctly documented.
The purpose of the students' research was to determine if primary care providers
are complying with AAOS CPG and identify the treatment/management options most
commonly chosen. Bedard et al. (2018) hypothesized that all specialty providers are
aware of the 2008 and 2013 clinical practice guidelines for the treatment of knee
osteoarthritis which were assessed in the current study.
The last study discussed in this review of literature involves a management
option, platelet-rich plasma intra-articular (PRP IA), that is possibly being used in the
absence of sufficient evidence (Di Sante et al., 2016). AAOS guidelines do not refer to
this management option, but it is beginning to show up when reviewing the literature.
Di Sante et al. addressed the use of PRP IA in 43 patients with OA of the hip. The
students' research attempted to determine if PRP IA is being used in the treatment of
knee OA.
Di Sante et al. (2016) employed a quasi-experimental study with a view of
comparing the efficacy of platelet-rich plasma (PRP) therapy versus intra-articular
injection of hyaluronic acid (HA) in treating hip osteoarthritis (OA). OA is increasingly
becoming the most popular cause of chronic pain among the elderly aged 55 years and
older. According to Di Sante et al. (2016), it is a degenerative condition that
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precipitates functional disabilities, especially in cases involving the hip joint. As such,
the condition leads to deterioration of joint cartilages and the development of
osteophytes, hence causing mechanical breakdown of the hip joint. With the reported
increase in the population of hip OA patients, research has significantly focused on
establishing effective therapeutic interventions. Di Sante et al.'s (2016) work focused
on prior research on the continued use of PRP IA and IA injection of HA therapeutic
inteiventions. W hile Di Sante et al. established evidence that offers a significant basis
of making justifiable generalizations regarding the efficacy of the featured hip OA
therapies, there were apparent limitations with respect to the sample, hypothesis, and
follow-up duration.
Di Sante et al. (2016) fundamentally focused on an important subject as
healthcare industry stakeholders attempt to address the worrying arthritis trend in adult
populations across the globe. By hypothesizing that PRP IA therapy and HA IA
treatment are the best hip OA therapeutic interventions, Di Sante et al. (2016) focused
on investigating which one of the two interventions was the most effective. Even
though Di Sante et al. failed to develop an hypothesis or a more precise research
question that would be pivotal in guiding their research, their study definitely was based
on establishing evidence to answer whether PRP IA or HA IA was the most effectual in
treating the disease. Therefore, it is generally justifiable to perceive that the study
sought to answer which therapy, between PRP IA and HA IA, is effectual in treating hip
OA in adults.
The comparison between PRP IA and HA IA was based on a sample size of 43
OA p atients who were randomized into either PRP group (n = 21) or HA group (n =
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22). The study population included both the female and male consecutive patients who
were diagnosed with the condition and met the set inclusion criterion. It was also
imperative to balance both clinical and demographic characteristics of participants to
achieve well-balanced groups. Following a random assignment of participants in either
HA or FRP by an independent person. Di Sante et al. (2016) followed an ethical
approach from developing clinical outcome measures, preparing platelet-rich plasma,
undertaking therapeutic procedures, to making follow-up appointments. The study
protocol was generally ethical as the threshold set by the local ethics committee was
substantially met and efforts made to harness informed consent from the participants.
Following statistical analysis of the clinical outcomes, Di Sante et al. established
a basis for ascertaining the efficacy of each of the therapies. In the PRP group,
immediate effect on pain was recorded within the first 4 weeks and eventually lost
afterwards. According to Di Sante et al. (2016), PRP IA therapy yielded a short-lived
effect within the 4 weeks on hip joint pain since it was not maintained in subsequent
follow-up. Thus, the PRP group had recorded relatively higher factional visualanalogue scale (VAS) and Western Ontario and McMaster Universities (WOMAC) OA
index scores at an early stage. Nevertheless, the scores diminished with time. On the
account of HA group, WOMAC and VAS scores were relatively higher in the long
run— unlike in the first 4 weeks where PRP group had taken an early lead in scores. It
was generally evident that the HA score after 16 weeks was high, hence its
effectiveness in long-term treatment of hip OA.
In spite of the valid outcomes that led to justifiable generalizations regarding
PRP IA and HA IA, the research by Di Santi et al. raised significant concerns. By
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lacking a clearly stated hypotheses or research question, the scope of the study is
questionable and confirmed by the fact that some outcome measures which were
included were redundant (Di Sante et al., 2016). It is noted that the study overlooked a
control group that would otherwise offer a foundation of ascertaining if the change in
pain patterns as per the scores were vindicated (Di Sante et ah, 2016). Through limiting
the study to a small sample size of 43 participants, who are all engaged in therapeutic
procedures, the study fails to come up with a control group for the purposes of
ascertaining the study results. The maximum follow-up duration of 16 weeks which the
study employed is also relatively insufficient since OA treatment is usually on a longterm basis. However, eliminating conflict of interest and maintaining an error of 0.2
through the use of a manageable sample size fostered attainment of valid and verifiable
research outcomes.
Considering all the study aspects, it is imperative to acknowledge the pivotal
role played by the researchers (Di Sante et al., 2016) in advising the various parties in
the healthcare sector who envision managing hip OA. Di Sante et al. presented valid
outcomes that informed providers and patients regarding the effectual OA therapy. This
implies that the study results offered an evidential basis of recommending HA IA as the
most appropriate treatment of the condition. 1 herefoie, Di Sante et al. (2016) informed
interested parties to take a stand in the ongoing controversial discussion regarding OA
treatment. It is generally acceptable to perceive that, although the sample size was
small (N = 43), the research is a significant pillar in the global efforts geared toward the
reduction of joint pain linked to knee osteoarthritis. More research studies will need to

focus on whether or not HA ]A and PRP IA would be a significant alternative for
patients with knee osteoarthritis.

Summary
In conclusion, the above research studies emphasized the need for further
research into the compliance of PCP with AAOS guidelines concerning treatment of
knee OA. Multiple studies mentioned above found that the most common
treatment/management options chosen were not those recommended by the AAOS
guidelines. The students' research will identify whether or not there has been an
improvement in compliance with the clinical practices of PCP in the treatment of OA
if treatment/management options that are not recommended are still being commonly
chosen.
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CHAPTER III
Methodology
1 he American Academy of Orthopaedic Surgeons (AAOS) published a series of
evidence-based guidelines for treatment ol knee osteoarthritis (OA). The student
researchers focused on AAOS guidelines tor treatment of osteoarthritis of the knee
when studying compliance with these guidelines among primary healthcare providers.
Primary healthcare facilities are the portal into the healthcare system for most patients.
I his places the primary healthcare provider in a unique position to intervene and
educate patients on their treatment/management options for OA of the knee. The
researchers sought to identify AAOS compliance and the most common management
options primary healthcare providers utilized for the treatment of OA.
Design
A survey was sent to primary healthcare providers via social media and email
using Google Forms. The survey included five clinical vignettes based on the Kellgren
and Lawrence radiographic system for classification of knee OA. Respondents selected
their top three treatment/management options currently supported or not supported by
the AAOS guidelines.
Setting
The current researchers received permission from Rex Lutz, the research
correspondent from the study compliance with the AAOS guidelines for treatment of
osteoarthritis of the knee (Carlson et ah, 2018) to utilize and modify the five clinical
vignettes previously used in a survey of orthopaedic surgeons (see Appendix A). This
research polled healthcare providers in the U.S. Social media was utilized to send out

emails with the vignettes containing an x-ray for each vignette along with 12 options to
choose from on a Google forms survey platform. Collected data were not used to
identify any individual primary healthcare provider, and the research committee
maintained the email list separate from the survey databases.
Population and Sample
The population for this study included primary healthcare providers in the U.S.
The use of social media platform for the questionnaire did not guarantee responses from
a specific geographical area nor from only primary care providers.
Methods of Data Collection
Prior to initiation of the research, approval for the study was given by the
Mississippi University for Women (MUW) Institutional Review Board (IRB) (see
Appendix B). After approval from the IRB. the research group sent emails with the
Google forms survey platform with the five attached vignettes to healthcare providers in
the U.S. (see Appendix C). Empirical data were collected regarding the frequency in
which the healthcare providers utilize specific treatment/management options when
treating OA of the knee. To protect confidentiality and ensure no harm to the patients
or healthcare providers, the empirical data did not include any patient or healthcare
provider identifiers. Data only included management options and how often the
healthcare provider utilized each treatment. Data were collected from I ebruary 2019
through May 2019. Data were then combined for analysis. The information was
housed on a password-protected thumb drive and kept in the locked drawer of the
faculty advisor. The thumb drive was destroyed after analyzing data.
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Methods of Data Analysis
Once all data were collected, a descriptive statistical analysis was conducted on
the information. Frequencies regarding which treatment/management options are used
by the primary healthcare providers were described as a percentage of total treatment
rates. The student researchers also compiled a comparison of recommended
management options versus non-recommended management options that were being
utilized. Different levels of classification of OA were used for the vignettes. Pertinent
data were illustrated using visual aids such as pie charts and histograms, which provided
insight into frequency distribution, standard deviation, mean, median, and mode.
Additional Information
No incentives were provided to any healthcare provider to participate in this
research. At the conclusion of the study, a letter was drafted and delivered to Mr. Rex
Lutz thanking him for allowing the researchers to utilize and modify the five clinical
vignettes and expressing our appreciation for his cooperation (see Appendix D). A
copy of the research was provided to Mr. Lutz.
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CHAPTER IV
Presentation of Findings
This reseaich project delved into compliance with evidence-based guidelines for
tteatment of osteoarthritis of the knee established by the American Academy of the
Orthopaedic Surgeons (AAOS). T he methodology utilized a survey sent by members of
the research team to primary care providers in the United States. The survey was
modified from the original survey that had been presented to active members of the
American Association of Hip and Knee Surgeons. Permission to use the survey was
obtained from Dr. M. Lutz, the research correspondent for the study on compliance with
the AAOS guidelines for treatment of osteoarthritis of the knee: A Survey of the
American Association of Hip and Knee Surgery (Carlson et ah, 2018). The modified
survey included five different clinical vignettes with x-rays based on the KellgrenLawrence radiographic system for classification of knee osteoarthritis (OA). The
respondents had the role of selecting management options that they currently utilized.
However, all options were not currently supported by the AAOS guidelines as indicated
in Table 1.
This chapter explains the results of the study using the modified survey which
focused on the choice of primary care providers as opposed to orthopaedic surgeons.
Outcomes of the different vignettes were presented, and participants identified the most
commonly utilized means of management.
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fable

Management Options

Management option

AAOS position
if present

Strength of
evidence

Weight loss if applicable

Recommended

Moderate

Physical therapy referral (strengthening
and low-impact aerobic exercises)

Recommended

Strong

Perform hyaluronic acid intra-articular
injections or referral for same

Cannot
recommend

Strong

4

NSAIDs (oral or topical)

Recommended

Strong

5

Magnetic resonance image (MRI) of
the knee

Not listed

Not listed

Referral for arthroscopic interventions

Cannot
recommend

Strong

Insoles (e.g., lateral wedge) and/or
brace

Cannot
recommend

Strong

Supplements (e.g., glucosaminechondroitin)

Cannot
recommend

Strong

Perform corticosteroid intra-articular
injections or referral for same

Cannot
recommend
for or against

Inconclusive

10

Perform platelet-rich plasma (PRP) intra
articular injection or referral for same

Not listed

Not listed

11

Acetaminophen (oral)

Cannot
recommend
for or against

Inconclusive

(continued)
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Table 1 (continued)

Management option

AAOS position
if present

Strength of
evidence

12

Referral for total knee arthroplasty

Recommended

Strong

13

Opioids (oral or transdermal patch)

Camiot recommend
for or against

Inconclusive

14

Referral for acupuncture

Cannot recommend

Strong

Demographics
The survey was completed by 102 participants. The criteria for the participants
were licensed professionals that practiced in primary care. The participants consisted of
nurse practitioners (n = 89, 87.3%), medical doctors (n = 8, 7.8%), physician assistants

(n = 2, 2%), and doctor of osteopathic medicine (n= 1,1%). Two (2%) students were
included in the data. Due to lack of licensure, the 2 (2%) students who responded to the
survey should have been omitted from the statistical data. However, this oversight was
considered a limitation of the study. Table 2 indicates the participants who took part in
the study according to specialty.
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Table 2

Statistical Results According to Specialty

%
Indicated specialty

/

%

Valid

Cumulative

Valid nurse practitioner (NP)

89

87.3

87.3

87.3

Medical doctor (MI))

8

7.8

7.8

95.1

NP student

1

1.0

1.0

96.1

Student

1

1.0

1.0

97.1

Physician assistant (PA)

2

2.0

2.0

99.0

Doctor of Osteopathic Medicine (DO)

1

1.0

1.0

100.0

102

100.0

100.0

Total

Research Questions
The current study sought to answer the following research questions:
1. Are primary care providers compliant with the AAOS treatment of
osteoarthritis of the knee guidelines?
2. What are the most common management options chosen by primary care
providers for knee osteoarthritis?
In order to answer the research questions, five different vignettes consisting of
scenarios and x-rays of patients' knees with OA were presented in the survey to the
participants. Each of the participants selected the top three management options they
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would initiate for each patient in no particular order. Discussed below are the statistical
results oi the five vignettes and the three most selected management options chosen for
each oi the vignettes by the primary care providers who took part in the survey.
Statistical Results

Listed below are the three most common management options selected by the
survey participants and sorted by scenario:
Scenario 1

An active 64-year-old Hispanic female was seen in clinic with a main complaint
of right knee pain. She had symptoms for 2 years but had never seen a doctor for the
pain. What would you recommend for this patient at this time (top three choices)? The
three answers most often selected by the respondents when interpreting their
management option of care for this patient scenario were weight loss, NSAlDs, and
physical therapy.
Eighty (26.1%) of the total respondents chose weight loss as one of their top
three management options. According to the guidelines, weight loss is a moderately
recommended intervention. Seventy-eight (25.5%) of the total respondents chose
NSAlDs (oral or topical) as one of their top three management options. According to
the AAOS, evidence-based guidelines for treatment of knee osteoarthritis use of
NSAlDs are strongly recommended. Seventy-six (24.8%) of the total respondents
chose physical therapy referral (strengthening and low-impact aerobic exercises) as one
of their top three management options. According to the AAOS, evidence-based
guidelines for treatment of knee osteoarthritis physical therapy referral for strengthening
and low-impact aerobic exercises are strongly recommended.
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Scenario 2
A 74 >eai-old diabetic male had been experiencing bilateral knee pain—left knee
woise than light knee. 1 his gentleman takes Advil a couple of times per week and
previously participated in physical therapy with minor relief. Which of the following
would you recommend tor this patient at this time (select top three choices)?
1 he thiee answers most often selected by the respondents when interpreting their
management option of care for this patient scenario were weight loss, perform
corticosteroid intra-articular injections or referral for same, and Magnetic Resonance
Image (MRI) of the knee.
Eighty (26.1 %) ot the total respondents chose weight loss as one of their top
three management options. According to the AAOS guidelines, weight loss is a
moderately recommended intervention. Fifty-three (17.3%) of the total respondents
chose to perform corticosteroid intra-articular injections or referral for same as one of
their top three management options. According to the AAOS, evidence-based
guidelines for treatment of knee osteoarthritis, corticosteroid intra-articular injections
are neither recommended nor suggested to use. The evidence for the use of
corticosteroid intra-articular injections is inconclusive. Thirty-eight (12.4%) of the
respondents chose to perform an MRI of the knee as one of their top three management
options. The AAOS evidence-based guidelines for treatment of knee osteoarthritis do
not list MRI as a management option. A study by Menashe et al. (2012) found that
sensitivity of MRI is below the current clinical diagnostic standards. The most effective
method for diagnosing osteoarthritis is the use of standard clinical algorithm aided by
radiographs.
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Scenario 3
A 68-yeai-old male presented to clinic complaining of left knee pain of 10 years
duration. I he pain had worsened over the past year and now limits his ability to
perloim tasks around his home. Previously, his symptoms responded to physical
therapy and intra-articular injections (cortisone with viscosupplementation). However,
following his most recent injection, he experienced no relief and remained unable to
participate in physical therapy due to the pain. Which of the following would you
recommend for this patient at this time (select top three choices)? The three answers
most often selected by the respondents when interpreting their management options of
care for this patient scenario were referral for arthroscopic interventions, referral for
total knee arthroplasty, and weight loss if applicable. Sixty-five (22.4%) of the total
respondents chose referral for arthroscopic interventions as one of their top three
management options. According to the AAOS, evidence-based guidelines for treatment
of knee osteoarthritis arthroscopic interventions are strongly not recommended. Fiftythree (18.3%) of the total respondents chose referral for total knee arthroplasty as one of
their top three management options. According to the AAOS, evidence-based
guidelines for treatment of knee osteoarthritis total knee arthroplasty are strongly
recommended. Forty-one (14.13%) of the total respondents chose weight loss if
applicable as one of their top three management options. According to the guidelines,
weight loss is a moderately recommended intervention.
Scenario 4
A 52-year-old female reported with bilateral knee pain of 4 months duration.
She described the pain as dull and noted that it tends to worsen toward the end of the
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day. She took I ylenol prior to volunteering tor a local fundraiser and was able to
complete hei assigned tasks. Which of the following would you recommend for this
patient at this time (select top three choices)? The three answers most often selected by
respondents when interpreting their management options of care for this patient
scenario were weight loss (if applicable), NSAIDs (oral or topical), and physical
therapy referral (strengthening and low-impact aerobic exercises). Eighty-seven
(28.4%) of the total respondents chose weight loss (if applicable) as one of their top
three management options. According to the guidelines, weight loss is the moderately
recommended intervention. Seventy-five (24.5%) of the total respondents chose
NSAIDs (oral or topical) as their top three management options. According to the
AAOS, evidence-based guidelines for treatment of knee osteoarthritis use of NSAIDs
are strongly recommended. Seventy-three (23.9%) of the total respondents chose
physical therapy referral (strengthening and low-impact aerobic exercises) as one of
their top three management options. According to the AAOS evidence-based guidelines
for treatment of knee osteoarthritis, physical therapy referral for strengthening and lowimpact aerobic exercises is strongly recommended.
Scenario 5

An active 58-vear-old female complained of worsening bilateral knee pain. She
first experienced the pain in her mid to late 40s. Previously, she received physical
therapy and an intra-articular injection (cortisone with viscosupplementation) with some
relief. Which of the following would you recommend for this patient at this time (select
top three choices)? The three answers most often selected by the respondents when
interpreting their management options of care for this patient scenario were weight loss
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(if applicable), NSAlDs (oial or topical), and physical therapy referral (strengthening
and low impact aerobic exercises). Fifty-live (18.1%) of the total respondents chose
weight loss, if applicable, as one ot their top three management options. According to
the guidelines, weight loss is a moderately recommended intervention. Forty-three
(14.1 /o) ol the total respondents chose NSAIDs (oral or topical) as one of their top three
management options. As discussed in Scenario 1, use of NSAIDs is strongly
recommended. Forty-one (13.5%) of the total respondents chose physical therapy
referral (strengthening and low-impact aerobic exercises) as one of their top three
management options. Physical therapy is strongly recommended in AAOS guidelines.
Overall, the most frequently chosen management options were weight loss,
referral for physical therapy. NSAIDs, referral for arthroscopic interventions, referral
for total knee arthroplasty, corticosteroid intra-articular injections or referral for same,
and an MRI. These data showed continual use of management options that are not
recommended, such as arthroscopic interventions and cortisone injections. Other
options that were chosen less frequently and had strong evidence against using were
insoles and/or brace, hyaluronic acid intra-articular injections, and supplements (e.g.,
glucosamine-chondroitin). Acetaminophen and opioids had inconclusive
recommendations based on the evidence available. The primary care providers were
given the opportunity to choose an MRI as a management option although AAOS has
no guidelines for this. Another area added to this survey was platelet-rich plasma (PRP)
injections. This injection is not mentioned in the AAOS evidence-based guidelines, but
there is an increasing trend to perform this procedure. The current authors of this study
were curious to see if primary care providers were aware of this injection option. Data

44

showed that PRP was chosen by one or more than one participant as a management
option ovei the five scenarios but never in the top three most frequent management
options. MR1 was selected as a management option in all scenarios.
Additional Findings

1 he AAOS guidelines strongly recommend against the use of hyaluronic acid
but do not recommend for or against use of intra-articular corticosteroid injection based
on current evidence. Once each scenario was evaluated further, it was noted that
cortisone injections were chosen more often than hyaluronic acid injections in the
respondents' top three choices: Scenario 1: 3.9% IA cortisone vs. 1.3% 1A hyaluronic
acid: Scenario 2: 17.3% IA cortisone vs. 7.8% IA hyaluronic acid; Scenario 3: 1% 1A
cortisone vs. 5.2% IA hyaluronic acid; Scenario 4: 1.6% IA cortisone vs. 1% IA
hyaluronic acid; and Scenario 5: 11.5% IA cortisone vs. 6.3% IA hyaluronic acid.
Another significant finding of the study was the selection of pain medication,
e.g. NSAlDs, acetaminophen, and opioids. In Scenarios 1, 4, and 5, NSAIDs were one
of the top three management options chosen by the participants; whereas,
acetaminophen was only selected by 27 (8.8%) in Scenario 1, 28 (9.2%) in Scenario 4,
and 9 (3%) in Scenario 5. On the other hand, opioids were not selected as a
management option by anv of the participants in Scenarios 1, 4. and 5. In Scenario 2,
acetaminophen (r? = 23, 7.5%)) was recommended almost at the same rate as NSAIDs (/?
= 22, 7.2%). The patient had tried Advil in an inadequate dose with minor relief.
Scenario 3 had 20 participants (n = 20. 6.9%) who selected opioids as one of their
management options, which was higher than NSAIDs (n — 12, 4.1 /o) and

acetaminophen („ = 8, 2.8%). The patient description and x-rays in Scenario 3 were
consistent with "bone on bone" contact and worsening arthritis.
The majority of respondents chose referral for arthroscopic intervention ( n = 65,
22.4/o) in theii top three choices for Scenario 3. Arthroscopic intervention is rarely
indicated for severe arthritis. 1 his recommendation is strongly not recommended by
AAOS. Total knee arthroplasty (n = 53. 18.3%) is the treatment of choice at this stage
in the patient's care.
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CHAPTER V
Summary, Conclusions, and Recommendations
Each year more and more people are diagnosed with a debilitating disease
known as osteoarthritis of the knee. It not only affects the person, but it also has an
enormous financial

impact on the economy within the U.S. The goal of this study was

to determine the compliance of primary care providers with the American Academy of
Orthopaedic Surgeons (AAOS) Guidelines of Knee Osteoarthritis (OA) and identify the
most commonly used treatment/management options chosen by primary care providers
for knee osteoarthritis. This research sample (N — 102) included primary care providers
to determine the most common management option and whether or not primary care
providers are following AAOS guidelines for OA of the knee.
Previously reviewed research in Chapters II and III indicated that compliance
with AAOS guidelines are not being followed and. in return, causing an increase of
unnecessary expenses. Some providers participated in non-recommended injections
(Carlson, et. al. 2018). Also, most of the common management options used by
primary care providers and surgeons are not recommended by AAOS, e.g., excessive
use of intra-articular (IA) hyaluronic acid injections by surgeons for moderate to severe
OA in spite of it not being a recommended guideline (Carlson, et, al, 2018). Another
study found the most common management options being used by primary care
providers that are not recommended by AAOS guidelines included HA injections, CS
injections, and opioid medication (Bedard et. al. 2017). This research focused on
management options used by primary care providers while following recommended
guidelines.
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The reseaich statistical data will be summarized in this chapter. Interpretation
of the lesults and implications of the Chronic Care Model and how it relates to OA and
AAOS guidelines will be presented. Additional recommendations will be discussed
based on statistical data of the research, i.e., providing more education to providers on
being compliant with AAOS guidelines.
Summary of the Findings
Out ol the 100 qualified licensed providers who participated in the survey, the
majority were nurse practitioners. Other participants were medical doctors, physician
assistants, and Doctor of Osteopathic Medicine (DO). All participants were given five
scenarios, and they had to choose their top three treatment/management options.
Survey participants were anonymous.
Statistical data established that primary care providers were overall compliant
with AAOS guidelines for moderate to severe OA of the knee. This overall compliant
status was determined by their top three choices they recommended for each scenario.
Outside of the top three choices, there were treatment/management options chosen by
providers that are not recommended AAOS Guidelines, yet they are being used today
(e.g., referral for acupuncture, supplements like glucosamine-chondroitin. and
insoles/wedges just to name a few). Weight loss was in the top three chosen
management options providers recommended if the patient s BMI was > 25/o in all live
scenarios. Since the health and well-being of the patient are to maintain a healthy
weight, that was probably the main factor chosen during the survey. In previous
studies, a 5% weight loss helped the patient improve with function and have a reduction
of pain (Atukorala et ah, 2016).
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Discussion of the Findings

Accoiding to AAOS guidelines, preferred treatment/management options chosen
by the providers in the scenarios were overall compliant with current guidelines.
NSAIDs were strongly recommended, physical therapy for strengthening and lowimpact aeiobic exercise were strongly recommended, weight loss was moderately
recommended for a BMI > 25kg/m2. These findings in the long run can provide a
beltei quality of lite. NSAIDs were recommended over acetaminophen. In studies
from 2008 the recommended daily dose of acetaminophens was 4000 mg per day; but,
in 2013. the daily recommended dose was decreased to 3000 mg per day (AAOS,
201 J). I here are not enough studies to show whether or not the decrease in daily dose
has been effective, but AAOS has it classified as inconclusive until further research can
be performed.
Corticosteroid intra-articular injections were inconclusive due to the lack of
studies and consistent with IA cortisone being a "gold standard" for arthritic joints for
years. Primary care providers may not be as familiar with the indication for IA viscous
supplementation. Most PCPs do not perform this type of injection in their practice
(Carlson et al., 2018). However, the main implication was that PCPs are still doing or
referring patients for joint injections although AAOS has inconclusive
recommendations.
MRI was not listed as a recommended management option, arthroscopic
intervention was not recommended, and arthroplasty was strongly recommended. In
Scenario 3, when arthroscopic intervention was selected, it is not recommended as
treatment because x-ray of knee showed bone on bone contact. According to previous
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research (Dhawan et al., 2014). arthroscopic interventions are not recommended unless
a meniscal tear or a loose body is present.
In a previous study, researchers found osteoarthritis is the leading cause of
disability and is one of the leading contributors to healthcare costs. Bedard et al. (2017)
sought to determine the cost of OA in the year leading up to total knee arthroplasty
(1KA). Treatment interventions were assessed by CPT codes including hyaluronic acid
(HA) injections, corticosteroid injections (CS), physical therapy (PT), braces, wedges,
insoles, opioids, prescription non-steroidal anti-inflammatories (NSAIDS), and
tramadol. These treatments were only assessed when they were directly linked to a
diagnosis of knee OA. Bedard et al. (2017) showed there was an alarming increase of
costs associated with providers who did not follow recommended clinical practice
guidelines. According to the current study, other treatment/management options chosen,
but not recommended guidelines, included MRI. insoles, wedges, glucosaminechondroitin, and acupuncture.
Carleson et al. (2018) conducted a research study among orthopaedic surgeons
to determine if they were in compliance with AAOS guidelines for moderate to severe
OA. After completion of the study, it was discovered the guidelines were not being
followed. Carson et al.'s study revealed intra-articular (IA) hyaluronic acid injections
for moderate to severe OA was being used by the surgeons and that is not current
recommended guidelines (2018). Corticosteroid IA injections weie also discovered as
one of the top three treatment/management options in Scenaiio 2. AAOS guidelines do
not recommend or oppose the option for corticosteroid IA injections, therefore, it
remains inconclusive.

50

I he use of AAOS guidelines was highly recommended to improve treatment
consensus and patient outcomes. AAOS had used four level 1 clinics to carry out trials
on the effectiveness oi the use of 1A corticosteroids in the treatment of OA and
recommendations and reports compiled on the same. The use of 1A corticosteroids and
hyaluronic acid in the treatment ol OA of the knee did not prove to alleviate the
symptoms (Bedard et ah, 2018). Several studies were conducted to establish the
effectiveness ot IA in treatment of knee OA, and they both were parallel with
recommendations of AAOS. Patients treated with intra-articular injections within 6
months oi undergoing knee surgery were at a higher risk of getting postoperative
infections as compared to patients treated more than 6 months prior to having surgery.
Postoperative infections appear to be time dependent with closer proximity between
injection and knee surgery increasing the odds of infection (Bedard et al., 2018).
The AAOS guidelines do not provide the reasons for or against the use of IA on
OA knee. It. however, does provide recommendations or guidelines that provide
valuable direction on the use of IA hyaluronic acid for symptomatic OA of the knee. IA
hyaluronic acid does not record any significant increase in change when used to treat
knee OA; therefore, it is not recommended for use. There exists a difference between
recommendations and the actual use of the IA injections; therefore, the primary care
providers need guidelines on what precisely should be done.
Conclusions
This study examined the compliance of primary care providers with the AAOS
guidelines for treatment of osteoarthritis of the knee. Data collected revealed that some
of the chosen management options still included a number of management options that
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were not supported by AAOS guidelines. The overall most commonly chosen
management options were weight loss, physical therapy referral, NSAIDS. referral for
arthroscopic interventions, referral for total knee arthroplasty, the performance of
corticosteroid intra-articular injections, and performing an MRI. The AAOS guidelines
recommend against the use of arthroscopic interventions and corticosteroid intra
articular injections. Furthermore, the researchers also found that PCPs chose plateletrich plasma intra-articular injections, although this procedure is not in the AAOS
guidelines. I his procedure was not discussed in the 2012 guidelines, but current
research is being performed by several sources and should be in the guideline update in
2020.
1 he researchers concluded that although some treatment/management options
chosen were not recommended, overall PCPs most frequently chose management
options that were recommended by AAOS guidelines. The management option not
recommended by AAOS guidelines that was most commonly chosen throughout each
scenario in the current research was the use of acetaminophen. These findings were not
consistent with the previous study of compliance of orthopaedic surgeons with AAOS
guidelines. Carlson et al. (2018) concluded that "management of moderate to severe
knee OA does not align with AAOS guidelines' (p. 103). Carlson et al. (2018) also
noted that "intra-articular hyaluronic acid injections was the most commonly selected
intervention not recommended by the AAOS" (p. 103). The current researchers also
found it significant to note that there was a decline in opioid use as a chosen
management option. Opioid use was not chosen in Scenarios 1, 4, and 5, and only one
person chose it in Scenario 2. Respondents chose opioids the most in Scenario a. It is
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important to note that this vignette was a patient with bone-to-hone contact identified on
x-ray with no relief found in other options.
Limitations

The out lent leseaichers noted some limitations to their research. The first
limitation ol the study was the requirement that the respondents select three therapeutic
management options in no particular order per vignette. Ranking the order of all the
options would help identify preferred management choices further. Not providing each
primaiy care provider's place of employment or specialty limited the demographic
information needed to help identify non-primary care providers and give a more
accurate sample. 1 here were also students (n = 2) who responded to the survey, and
their responses were not clinically significant due to lack of primary care experience.
Also, the results could not identify the potential influence that could have been
originated by the patient on the primary care provider's decision on treatment method.
If the patient requested or desired specific management options, this could have altered
what management options the PCP chose for treatment/management options. Another
limitation to the study was that the scenarios did not have weight or BMI listed. It is
likely that the respondents assumed each patient to be overweight, hence including
weight loss in the treatment plan.
Implications
The Chronic Care Model was applicable to this research project in identifying
the compliance of primary care providers with AAOS guidelines for treatment of knee
OA in that it focused on the interventions that are being pio\ ided by the primary care
providers. The Chronic Care Model is an evidence-based framework that helps to
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identify essential components of the healthcare system that can be modified to improve
patient care outcomes. The Chronic Care Model relates to the current research project
because it focuses on the interventions that are being provided by the providers and
identifies the compliance of primary care providers with AAOS guidelines of knee
osteoarthritis.
Osteoarthritis is a chronic illness that affects hundreds of thousands of people
every year. Osteoarthritis of the knee is one of the most prevalent types of
osteoarthritis. 1 lauk (2014) determined that there are approximately 240 per 100.000
peisons per year that are diagnosed with knee osteoarthritis. Due to the high rates of
knee osteoaithiitis. it is imperative that guidelines be followed for the most effective
treatment.
I his research revealed that PCPs commonly choose treatment/management
options that are recommended by the AAOS guidelines. The research also revealed that
some treatment/management options are still being chosen and are not recommended by
the AAOS guidelines. Therefore, a need for further education concerning the effective
treatment of knee osteoarthritis recommended by evidence-based guidelines is
suggested. This education could be provided through continuing education
opportunities.

Recommendations
Based on the outcomes of this study, a number of recommendations for practice
and research are needed. These practice recommendations are based on the AAOS
guidelines of treatment of knee osteoarthritis. To better address this issue, primary care
providers should be aware of the AAOS guidelines. Therefore, education regarding the
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A AOS guidelines should be a top priority. The recommended treatment/management
options include weight loss, if applicable, physical therapy referral, NSAIDS, and
referral loi total knee arthroplasty. With treatment/management options that are not
recommended by the AAOS being commonly chosen by primary care providers, it is
imperative that this knowledge deficit be addressed. Ihis education should also include
that treatment/management options not recommended by AAOS include hyaluronic
acid intra-articular injections, referral for arthroscopic interventions, insoles and/or
brace, supplements, corticosteroid intra-articular injections, acetaminophen, opioids,
and reterral tor acupuncture. Furthermore, education needs to include that platelet-rich
plasma intra-articular injections are not listed as recommended or non-recommended
options. Also recommended was providers should be apprised of the fact that new
guidelines are scheduled for release by the AAOS in 2020. Primary care providers are
in a prime position to identify and treat knee osteoarthritis effectively. By increasing
education of the AAOS guidelines among PCPs, the management options of knee
osteoarthritis can be more current.
Based on the outcomes of this study, replication of this study would be ideal
with focus toward eliciting more participants from all over the U.S. and also limiting the
study to only primary care providers. 1 he current researchers also recommend that
participants should be able to select interventions in order of importance that would
help to more adequately evaluate the care practices of the PCPs when treating
osteoarthritis of the knee.
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APPENDIX A
Permission to Use Survey

Mr. Lutz,
I would like to ask permission 011 behalf of my research group if we could use your
survey questions that you used for the study on Compliance with the AAOS Guidelines
toi the treatment of OA of the knee, A survey of the American Association of Hip and
Knee Surgeons and modify them or exclude some to fit our study for the compliance
with the AAOS Guidelines for the treatment of OA of the knee and survey Nurse
Practitioners. We are a graduate program for MSN-FNP at Mississippi University for
Women currently researching the compliance of Nurse Practitioners on the guidelines
for treatment of OA of the knee. One of our group members critiqued your article and
we would like to continue the survey your study used and modify the vignette to use for
Nurse Practitioners.
We look forward to your reply.
Thank you,
Catherine M. Eldridge, BSN, RN

Reply:Hi Catherine.
We would be happy to share the survey. 1 will send the link shortly.
Best,
Rex
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IRB Approval of Mississippi University for Women
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APPENDIX C
Survey Questionnaire
Research Study Questionnaire
Radicgraph of

knee

* Requirea

Radiograph of the knee

Kc teat ill NluUv QucsEKiamain:

1 An active 64 year-old hispanic female is seen in clinic with a main complaint of right knee pain.
She has had symptoms for 2 years, but has never seen a doctor for the pain. What would you
recommend for this patient at this time? (select top three choices) *
Check all that apply.
Referral for arthroscopic interventions
Perform hyaluronic acid intra-articular injections or referral for same
Physical therapy referral (Strengthenirrg and low-impact aerobic exercises)
Weight loss if applicable
Magnetic resonance image (MR!) of the knee
NSAlDs (oral or topical)
Perform corticosteroid intra articular injections or referral for same
Insoles (e.g.. lateral wedge) and-'or brace
Supplements (e g glucosamine-chondroitin)
Acetaminophen (oral)
Referral for total knee arthroplasty
Referral for acupuncture
Perform Platelet rich plasma (PRP) intra articular injection or referral for same
opioids {oral or transdermal patch)
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Research Study Questionnaire
Vignette 2

Radiograph of the knee

tuipv. IK-V%.GOO}'U: 4.\>ITI LURING J 1H O^.IIYVS (,V:VR.K C36»IVIIQ\HXBCiN#>N< IJIIKZ*. NXIX>N*>1AI edit

7/9/20IV

Research Study Qucstiorinain:

2 A 74 year-old diabetic male has been experiencing bilateral knee pain, loft worse than right. He
takes Advil a couple of times per week and previously participated in physical therapy with
minor relief. Which of the following would you recommend for this patient at this time? (select
top three choices) '
Check all that apply.
Referral for arthroscopic interventions
Perform hyaluronic acid intra articular injections or referral for same
Physical therapy referral (Strengthening and low-impact aerobic exercises)
Weight loss if applicable
Magnetic resonance image (MRI) of the knee
NSAIDs (oral or topical)
Perform corticosteroid intra articular injections or referral for same
Insoles (e.g.. lateral wedge) and/or brace
Supplements (e.g.. glucosamine-chondroitin)
Acetaminophen (oral)
Referral for total knee arthroplasty
Referral for acupuncture
Perform Platelet rich plasma (PRP) intra articular injection or referral for same
opioids (oral or transdermal patch)
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Research Study Questionnaire
Vignette 3

Radiograph of the knee

3 A 68 year-old male presents in clinic complaining of left knee pain of 10 years duration. The
pain has worsened over the past year and now limits his ability to perform tasks around his
home. Previously, his symptoms responded to physical therapy and intra-articular injections
(cortisone with viscosupplementation). However, following his most recent injection, he
experienced no relief and remains unable to participate in physical therapy due to the pain.
Which of the following would you recommend for this patient at this time? (select top three
choices) *
Check all that apply.
Referral for arthroscopic interventions
Perform hyaluronic acid intra articular injections or referral for same
Physical therapy referral (Strengthening and low impact aerobic exercises)
Weight loss if applicable
Magnetic resonance image (MRI) of the knee
NSAlDs (oral or topical)
Perform corticosteroid intra articular injections or referral for same
insoles (e.g.. lateral wedge) and/or brace
Supplements (e.g.. glucosamine-chondroitin)
Acetaminophen (oral)
Referral for total knee arthroplasty
Referral for acupuncture
• Perform Platelet rich plasma (PRP) intra articular injection or referral for same
opioids (oral or transdermal patch)
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Research Study Questionnaire
Vignette 4

Radiograph of the knee

4 A 52 year-old female reports bilateral knee pain of 4 months duration. She describes the pain
as dull, and notes that it tends to worsen towards the end of the day. She took Tylenol prior to
volunteering for a local fundraiser and was able to complete her assigned tasks. Which of the
following would you recommend for this patient at this time? {select top three choices) *
Check all that apply

Referral for arthroscopic interventions
Perform hyaluronic acid intra-articular injections or referral for same
Physical therapy referral {Strengthening and low-impact aerobic exercises)
Weight loss if applicable
Magnetic resonance image (MRI) of the knee
NSAIDs (oral or topical)
Perform corticosteroid intra articular injections or referral for same
Insoles (e.g.. lateral wedge) and/or brace
Supplements (e.g.. glucosamine chondroitin)
Acetaminophen (oral)
Referral for total knee arthroplasty
Referral for acupuncture
Perform Platelet rich plasma (PRP) intra articular injection or referral for same
opioids (oral or transdermal patch)

Research Study Questionnaire
Vignette 5

Radiograph of the knee
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5 An active 58 year-old female complains of worsening bilateral knee pain. She first experienced
the pain in her mid-to-late 40s. Previously, she received physical therapy and an intra-articular
injection (cortisone with viscosupplementation) with some relief. Which of the following would
you recommend for this patient at this time? (select top three choices) "

Check all that apply
Referral for arthroscopic interventions

Perform hyaluronic acid intra articular injections or referral for same
Physical therapy referral (Strengthening and low impact aerobic exercises)
Weight loss if applicable
Magnetic resonance image (MRI) of the knee
NSAIDs (oral or topical)
Perform corticosteroid intra articular injections or referral for same
Insoles (e.g.. lateral wedge) and/or brace
Supplements (e g

glucosamine chondrcwtin)

Acetaminophen (oral)
Referral for total knee arthroplasty
Referral for acupuncture
Perform Platelet rich plasma (PRP) intra articular injection or referral for same
opioids (oral or transdermal patch)

Research Study Questionnaire
Participant specialty

6 Please indicate your specialty below: (select one)'
Mark only one oval.
Nurse Practitioner (NP)

Doctor ol Osteopathic Medicine (00)
Medical Doctor (MD)
Other:

